Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Faron Pharmaceuticals Share Price
  4. Faron Pharmaceuticals Share Regulatory News

Pin to quick picksFaron Pharmaceuticals Regulatory News (FARN)

Faron Pharmaceuticals Information

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (4.444%)
Market Cap: £91.78m
FARN Live PriceLast checked at - London Stock Exchange

Intraday Faron Pharmaceuticals Share Chart

12345678910
Date   Source Headline
31st Jan 20247:00 amRNSFurther re: Exercise of options
25th Jan 20247:00 amRNSBEXMAB Insights into Patient Profiles
19th Jan 20241:00 pmRNSExercise of options - Issue of equity
9th Jan 20247:00 amRNSFirst Patient Dosed in Ph 2 of the BEXMAB Trial
3rd Jan 20247:00 amRNSPresentation at J.P. Morgan Healthcare Conference
22nd Dec 20237:00 amRNSFaron’s Financial Calendar for 2024
11th Dec 20237:00 amRNSPhase 1 BEXMAB data presented at ASH
7th Dec 20237:00 amRNSMATINS Trial in Cell Reports Medicine
4th Dec 20237:00 amRNSGrant of options
6th Nov 20238:13 amRNSFaron Initiates Phase 2 Part of BEXMAB Study
6th Nov 20237:00 amRNSFaron Initiates Phase 2 Part of BEXMAB Study
2nd Nov 20231:00 pmRNSFaron to present data from BEXMAB study at ASH
27th Oct 20231:00 pmRNSManager's transactions
27th Oct 20237:15 amRNSExercise of options
27th Oct 20237:00 amRNSResults of Placing
26th Oct 20234:30 pmRNSProposed Issue and Placing
11th Oct 20237:00 amRNSFaron Announces Positive BEXMAB Study Update
3rd Oct 20237:00 amRNSFaron to host webcast on new BEXMAB study data
22nd Sep 20234:00 pmRNSBoard Changes
22nd Sep 202311:00 amRNSResults of EGM
21st Sep 20237:00 amRNSFaron Appoints Interim Chief Medical Officer
8th Sep 20237:00 amRNSChange in the Board of Directors
6th Sep 20237:00 amRNSFaron to Present at H.C. Wainwright Conference
1st Sep 202310:00 amRNSNotice of EGM
31st Aug 20232:00 pmRNSExercise of options
29th Aug 20237:01 amRNSFaron 2023 Half-Year Financial Results
29th Aug 20237:00 amRNSFDA Orphan Drug Designation for Bexmarilimab
4th Aug 20237:00 amRNSNotice of Half-Year Financial Results
2nd Aug 20237:00 amRNSFaron to Participate at Canaccord Conference
25th Jul 20237:00 amRNSGrant of Options
19th Jul 20237:01 amRNSFaron to Hold BEXMAB Study Conference Call
19th Jul 20237:00 amRNSBEXMAB study update
30th Jun 20234:52 pmRNSHolding(s) in Company
29th Jun 20237:00 amRNSAnnouncement of Placing
12th Jun 20237:00 amRNSExercise of options
9th Jun 20238:00 amRNSNew biomarker data from BEXMAB study at EHA2023
5th Jun 20237:00 amRNSBoard Member to Assume Transactional Advisor Role
24th Apr 20237:00 amRNSBexmarilimab Efficacy and Safety in MATINS Trial
19th Apr 20237:00 amRNSBexmarilimab KOL Event
18th Apr 20237:00 amRNSPoster Presentations at AACR 2023
17th Apr 20237:00 amRNSBEXMAB study update
13th Apr 20234:30 pmRNSFaron at Canaccord Oncology Virtual Conference
29th Mar 20237:00 amRNSAppointment of Chief Financial Officer
24th Mar 20231:35 pmRNSBoard Change
24th Mar 20231:30 pmRNSResults of AGM
22nd Mar 20237:00 amRNSPositive FDA Feedback to Progress Bexmarilimab
3rd Mar 20239:00 amRNSNotice of Faron Pharmaceuticals Ltd’s AGM
3rd Mar 20237:15 amRNSFaron´s Annual Report 2022 Published
3rd Mar 20237:00 amRNSFinancial Statement January 1 to December 31 2022
6th Feb 20236:00 pmRNSUpdate to Faron’s Financial Calendar for 2023
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
CHRT
Cohort
LSE
0.00%
IVPB
IVPB.L
LSE
0.00%
SEC
Strategic Eqty
LSE
0.00%
AADV
Albion. Dev Vct
LSE
0.00%
JESC
JESC.L
LSE
0.00%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
0.00%
GGP
Greatland Resources
LSE
0.00%
LLOY
Lloyds
LSE
0.00%
CPI
Capita
LSE
0.00%
GST
GSTechnologies
LSE
0.00%